Updated Apr. 18, 2013 at 6:16 a.m.

Premium Lock Chimerix IPO nets more than $107M for antivirals R&D

Published: 2013-04-17 15:32:00
Updated: 2013-04-18 06:16:50

Chimerix Chimerix

Chimerix, which does not yet have any commercially-available products, spent $27.8 million on R&D last year, according to filings. With a compound entering phase III clinical trials this year, Chimerix will shell out even more money on R&D....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll